Pulmonology Articles

Pulmonology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Rodrigo GJ et al. – Compared with control (placebo or salmeterol), tiotropium did not significantly increase the risk of adverse major cardiovascular events among COPD patients. Subgroup analysis suggested that smoking history can modify the risk of cardiovascular adverse events.

Related Articles

Bone mineral density and fractures in older men with chronic obstructive pulmonary disease or asthma
Osteoporosis International, 10/13/09    Relevance Score: 92%

Interaction in COPD experiment (ICE): A hazardous combination of cigarette smoking and bronchodilation in chronic obstructive pulmonary disease
Medical Hypotheses, 10/08/09    Relevance Score: 91%

Molecular Characterization of Chronic Obstructive Pulmonary Disease-Related Non-Small Cell Lung Cancer Through Aberrant Methylation and Alterations of EGFR Signaling
Annals of Surgical Oncology, 10/23/09    Relevance Score: 90%

Dietary habits of firstly admitted Spanish COPD patients
Respiratory Medicine, 11/18/09    Relevance Score: 89%

Tiotropium HandiHaler in the treatment of COPD: A safety review
International Journal of COPD, 10/29/09    Relevance Score: 89%

Today in COPD...keeping you current

Effects of formoterol and salmeterol on cytokine release from monocyte-derived macrophages
European Respiratory Journal , 11/25/09

Defective macrophage phagocytosis of bacteria in COPD
European Respiratory Journal , 11/24/09

Alterations in Lung Mast Cell Populations in Patients with COPD
American Journal of Respiratory and Critical Care Medicine, 11/20/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address